Chromatin structure regulation in transforming growth factor-β-directed epithelial-mesenchymal transition

被引:18
作者
Blumenberg, Miroslav
Gao, Shujuan
Dickman, Kathleen
Grollman, Arthur P.
Bottinger, Erwin P.
Zavadil, Jiri
机构
[1] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
[3] NYU, Sch Med, NYU Canc Inst, New York, NY 10016 USA
[4] NYU, Sch Med, Dept Med, Mt Sinai Med Ctr, New York, NY 10016 USA
[5] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA
[6] VA Med Ctr, Dept Med, Northport, NY USA
关键词
epithelial-mesenchymal transition; transforming growth factor-beta; aristolochic acid-I; gene expression regulation; hairy/enhancer-of-split-related repressors; polycomb-group proteins; histones; chromatin; POLYCOMB-GROUP GENE; GROUP PROTEIN EZH2; HISTONE METHYLTRANSFERASE ACTIVITY; H3; LYSINE-27; METHYLATION; TGF-BETA; SIGNALING PATHWAYS; TRANSCRIPTIONAL REPRESSOR; DEVELOPMENTAL REGULATORS; DIFFERENTIAL EXPRESSION; INTRACELLULAR DOMAIN;
D O I
10.1159/000101317
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Epithelial-mesenchymal transitions (EMTs) occur in organogenesis throughout embryonic development and are recapitulated during epithelial tissue injury and in carcinoma progression. EMTs are regulated by complex, precisely orchestrated cell signaling and gene expression networks, with the participation of key developmental pathways. Here we review context-dependent modules of gene regulation by hairy/enhancer-of-split-related (H/E(spl)) repressors downstream of transforming growth factor-beta (TGF-beta)/Smad and Notch signals in EMT and in other phenotype transitions such as differentiation and cancer. Based on multiple models of disease-related EMT, we propose that Polycomb group epigenetic silencers and histone-lysine methyl-transferases EZH1 and EZH2 are candidate targets of H/E(spl)-mediated transcriptional repression, in a process accompanied by replacement of modified core histone H3 with de novo synthesized histone variant H3.3B. Finally, we discuss the potential significance of this scenario for EMT in the light of recent findings on gene regulation by histone modifications and chromatin structure changes. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:162 / 174
页数:13
相关论文
共 139 条
[1]   Characterization of EZH1, a human homolog of Drosophila enhancer of zeste near BRCA1 [J].
Abel, KJ ;
Brody, LC ;
Valdes, JM ;
Erdos, MR ;
McKinley, DR ;
Castilla, LH ;
Merajver, SD ;
Couch, FJ ;
Friedman, LS ;
Ostermeyer, EA ;
Lynch, ED ;
King, MC ;
Welcsh, PL ;
OsborneLawrence, S ;
Spillman, M ;
Bowcock, AM ;
Collins, FS ;
Weber, BL .
GENOMICS, 1996, 37 (02) :161-171
[2]   Transcriptional profiling implicates TGFβ/BMP and Notch signaling pathways in ductular differentiation of fetal murine hepatoblasts [J].
Ader, T ;
Norel, R ;
Levoci, L ;
Rogler, LE .
MECHANISMS OF DEVELOPMENT, 2006, 123 (02) :177-194
[3]   The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly [J].
Ahmad, K ;
Henikoff, S .
MOLECULAR CELL, 2002, 9 (06) :1191-1200
[4]   Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-β signaling [J].
Ahmed, Shaheen ;
Nawshad, Ali .
CELLS TISSUES ORGANS, 2007, 185 (1-3) :131-145
[5]   TGF-β signaling in cancer -: a double-edged sword [J].
Akhurst, RJ ;
Derynck, R .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S44-S51
[6]   THE HUMAN REPLACEMENT HISTONE H3.3B GENE (H3F3B) [J].
ALBIG, W ;
BRAMLAGE, B ;
GRUBER, K ;
KLOBECK, HG ;
KUNZ, J ;
DOENECKE, D .
GENOMICS, 1995, 30 (02) :264-272
[7]   Notch signaling and cancer: emerging complexity [J].
Axelson, H .
SEMINARS IN CANCER BIOLOGY, 2004, 14 (05) :317-319
[8]   EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast [J].
Bachmann, IM ;
Halvorsen, OJ ;
Collett, K ;
Stefansson, IM ;
Straume, O ;
Haukaas, SA ;
Salvesen, HB ;
Otte, AP ;
Akslen, LA .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (02) :268-273
[9]   Histone methylation: Dynamic or static? [J].
Bannister, AJ ;
Schneider, R ;
Kouzarides, T .
CELL, 2002, 109 (07) :801-806
[10]  
Bates RC, 2005, CANCER BIOL THER, V4, P365